Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
Clinical trial NCT05552651 · UNKNOWN
Trial details
- NCT number
- NCT05552651
- Sponsor
- Tao Jiang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-20
- Primary completion
- 2023-12-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.